New Indications for TIPSs: What Do We Know So Far?

• Published in: Journal of clinical and experimental hepatology Vol. 13; no. 5; pp. 794 - 803
• Main Authors: Lapenna, Lucia, Di Cola, Simone, Gazda, Jakub, De Felice, Ilaria, Gioia, Stefania, Merli, Manuela
• Format: Journal Article
• Language: English
• Published: India Elsevier B.V 01.09.2023; Elsevier
• Subjects: Budd-Chiari syndrome; portal hypertension; portal vein thrombosis; Review; surgery; transjugular intrahepatic portosystemic shunt; AC; portal hypertension; transjugular intrahepatic portosystemic shunt; PTFE; HVPG; RefA; PVT; Budd-Chiari syndrome; BCS; MELD; PSVD; portal vein thrombosis; RecA; PH; LVP + A; HE; surgery; TIPS
• ISSN: 0973-6883; 2213-3453
• DOI: 10.1016/j.jceh.2023.01.017

Since 1988, transjugular intrahepatic portosystemic shunt (TIPS) has been an effective therapy for portal hypertension in many settings. Thanks to continuous technical improvements and a wiser selection of patients, excellent results have been achieved with this therapeutic strategy. The historical indications for TIPS placement, in the context of liver cirrhosis, such as refractory ascites and variceal bleeding are now well established and known. However, in recent years, new indications are emerging. These have been investigated and approved in some studies but are not yet included in guidelines and clinical practice. This review aims to highlight what is new for the role of TIPS in portal vein thrombosis (especially in patients awaiting liver transplantation), in recurrent ascites and not only refractory ascites, as a neoadjuvant therapy before abdominal surgery and, finally, in the setting of noncirrhotic portal hypertension. All these new aspects are addressed in this review with a critical approach based on the literature revision and clinical practice. Future research is needed to explore and validate the new role of TIPS in these scenarios. [Display omitted]